Primary care docs prefer rep-delivered samples, says study

Share this article:

Despite busier schedules and less time for a detail, most primary care physicians (PCPs) prefer to receive samples directly from a sales rep, in person, according to a DTW Marketing Research study.

The study, which surveyed 100 PCPs online, found that 73% of the respondents favored samples hand-delivered from a rep, versus 20% who said they preferred online e-sampling. Additionally, 75% of a given PCP's current samples had arrived via sales rep, compared with 15% of samples coming from an online request, according to survey results.

In a release on the study, Christine Alongi, VP competitive intelligence services at DTW, said the findings should “serve as a word of caution to marketers considering major changes in their sampling programs,” since e-sampling “may prove to be cost-efficient, [but] the end result could negatively affect the overall promotional mix for the brand.”

In June, Michael du Toit, EVP, client service and new business at Digitas Health, told MM&M that online e-sampling programs have been a boon for pharmaceutical companies, resulting in “an increase of sample requisition” by doctors. “The experience we've had with our clients has been that sample consumption went up,” as a result of e-sampling, du Toit said.

Algoni said the DTW study did not look at total sample requests and quantities among doctors receiving sales reps, compared with doctors using e-sampling programs.                

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?